Logo image of JBS

JBS NV-A (JBS) Stock Fundamental Analysis

NYSE:JBS - New York Stock Exchange, Inc. - NL0015002J37 - Common Stock - Currency: USD

13.92  -0.01 (-0.07%)

After market: 14.03 +0.11 (+0.79%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to JBS. JBS was compared to 91 industry peers in the Food Products industry. There are concerns on the financial health of JBS while its profitability can be described as average. JBS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year JBS was profitable.
JBS Yearly Net Income VS EBIT VS OCF VS FCFJBS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 1B 2B 3B 4B

1.2 Ratios

JBS has a better Return On Assets (4.24%) than 64.84% of its industry peers.
With an excellent Return On Equity value of 23.43%, JBS belongs to the best of the industry, outperforming 93.41% of the companies in the same industry.
With an excellent Return On Invested Capital value of 10.92%, JBS belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for JBS is significantly below the industry average of 28.18%.
The last Return On Invested Capital (10.92%) for JBS is above the 3 year average (8.84%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.24%
ROE 23.43%
ROIC 10.92%
ROA(3y)3.8%
ROA(5y)N/A
ROE(3y)18.79%
ROE(5y)N/A
ROIC(3y)8.84%
ROIC(5y)N/A
JBS Yearly ROA, ROE, ROICJBS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 10 20 30

1.3 Margins

The Profit Margin of JBS (2.29%) is comparable to the rest of the industry.
JBS has a better Operating Margin (6.04%) than 62.64% of its industry peers.
JBS has a Gross Margin of 15.01%. This is comparable to the rest of the industry: JBS outperforms 41.76% of its industry peers.
Industry RankSector Rank
OM 6.04%
PM (TTM) 2.29%
GM 15.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
JBS Yearly Profit, Operating, Gross MarginsJBS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 5 10 15

3

2. Health

2.1 Basic Checks

JBS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for JBS remains at a similar level compared to 1 year ago.
Compared to 1 year ago, JBS has a worse debt to assets ratio.
JBS Yearly Shares OutstandingJBS Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 200M 400M 600M 800M 1B
JBS Yearly Total Debt VS Total AssetsJBS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 2.81 indicates that JBS is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of JBS (2.81) is better than 67.03% of its industry peers.
A Debt/Equity ratio of 2.72 is on the high side and indicates that JBS has dependencies on debt financing.
JBS has a Debt to Equity ratio of 2.72. This is amonst the worse of the industry: JBS underperforms 89.01% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.72
Debt/FCF N/A
Altman-Z 2.81
ROIC/WACC2.1
WACC5.21%
JBS Yearly LT Debt VS Equity VS FCFJBS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 1.62 indicates that JBS should not have too much problems paying its short term obligations.
JBS has a Current ratio (1.62) which is in line with its industry peers.
JBS has a Quick Ratio of 1.62. This is a bad value and indicates that JBS is not financially healthy enough and could expect problems in meeting its short term obligations.
JBS has a Quick ratio (0.93) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 0.93
JBS Yearly Current Assets VS Current LiabilitesJBS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5B 10B 15B

3

3. Growth

3.1 Past

JBS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 988.51%, which is quite impressive.
JBS shows a small growth in Revenue. In the last year, the Revenue has grown by 5.85%.
EPS 1Y (TTM)988.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)5.85%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

JBS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.71% yearly.
Based on estimates for the next years, JBS will show a small growth in Revenue. The Revenue will grow by 5.27% on average per year.
EPS Next Y13.22%
EPS Next 2Y-5.61%
EPS Next 3Y8.71%
EPS Next 5YN/A
Revenue Next Year9.63%
Revenue Next 2Y6.19%
Revenue Next 3Y5.27%
Revenue Next 5YN/A

3.3 Evolution

JBS Yearly Revenue VS EstimatesJBS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B
JBS Yearly EPS VS EstimatesJBS Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.75, which indicates a very decent valuation of JBS.
Compared to the rest of the industry, the Price/Earnings ratio of JBS indicates a rather cheap valuation: JBS is cheaper than 86.81% of the companies listed in the same industry.
JBS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.03.
Based on the Price/Forward Earnings ratio of 9.81, the valuation of JBS can be described as reasonable.
90.11% of the companies in the same industry are more expensive than JBS, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.28, JBS is valued rather cheaply.
Industry RankSector Rank
PE 8.75
Fwd PE 9.81
JBS Price Earnings VS Forward Price EarningsJBS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JBS is valued cheaply inside the industry as 86.81% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.71
JBS Per share dataJBS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

JBS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.66
PEG (5Y)N/A
EPS Next 2Y-5.61%
EPS Next 3Y8.71%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 14.53%, JBS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.73, JBS pays a better dividend. On top of this JBS pays more dividend than 98.90% of the companies listed in the same industry.
JBS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 14.53%

5.2 History

JBS is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

DPN/A
EPS Next 2Y-5.61%
EPS Next 3Y8.71%
JBS Yearly Income VS Free CF VS DividendJBS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2022 2023 2024 0 1B 2B

JBS NV-A

NYSE:JBS (8/5/2025, 8:04:00 PM)

After market: 14.03 +0.11 (+0.79%)

13.92

-0.01 (-0.07%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)08-13 2025-08-13
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap15.44B
Analysts82.5
Price Target21.57 (54.96%)
Short Float %2.03%
Short Ratio3.31
Dividend
Industry RankSector Rank
Dividend Yield 14.53%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)42.8%
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)1.24%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.75
Fwd PE 9.81
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 2.05
P/tB 168.37
EV/EBITDA 4.71
EPS(TTM)1.59
EY11.42%
EPS(NY)1.42
Fwd EY10.2%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS69.59
BVpS6.8
TBVpS0.08
PEG (NY)0.66
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.24%
ROE 23.43%
ROCE 15.05%
ROIC 10.92%
ROICexc 12.94%
ROICexgc 18.09%
OM 6.04%
PM (TTM) 2.29%
GM 15.01%
FCFM N/A
ROA(3y)3.8%
ROA(5y)N/A
ROE(3y)18.79%
ROE(5y)N/A
ROIC(3y)8.84%
ROIC(5y)N/A
ROICexc(3y)10.32%
ROICexc(5y)N/A
ROICexgc(3y)14.74%
ROICexgc(5y)N/A
ROCE(3y)12.18%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 2.72
Debt/FCF N/A
Debt/EBITDA 3
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 0.93
Altman-Z 2.81
F-ScoreN/A
WACC5.21%
ROIC/WACC2.1
Cap/Depr(3y)84.24%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.34%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)988.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y13.22%
EPS Next 2Y-5.61%
EPS Next 3Y8.71%
EPS Next 5YN/A
Revenue 1Y (TTM)5.85%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year9.63%
Revenue Next 2Y6.19%
Revenue Next 3Y5.27%
Revenue Next 5YN/A
EBIT growth 1Y284.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y215.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y77.8%
OCF growth 3YN/A
OCF growth 5YN/A